David A. Siegel Edgewise Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 45,400 shares of EWTX stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,400
Previous 96,000
52.71%
Holding current value
$1.26 Million
Previous $1.73 Million
29.92%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
189Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$418 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$248 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$168 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$163 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$155 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.76B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...